Competition in this area is increasing, especially for genotype 1 (70% of cases)
In conference call there are three main issues revealed.
1. profit benefits from a favorable Japanese Yen exchange rate
2. company won’t see as much cost savings this quarter
3. will be delays to some products for enterprise data centers
Current quarter was so so - exchange rate and cost saving helped but wont happen in the next quarter.
Credit Suise sent note today with neutral rating (sell) with price target $66